Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma

BACKGROUND: Neoadjuvant chemotherapy and short-course radiotherapy followed by resection has been gaining recognition in the treatment of rectal cancer. Avelumab is a fully human immunoglobulin that binds Programmed Death-Ligand 1 (PD-L1) and prevents the suppression of the cytotoxic T cell immune r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Radiat Oncol
Hlavní autoři: Shamseddine, Ali, Zeidan, Youssef H., El Husseini, Ziad, Kreidieh, Malek, Al Darazi, Monita, Turfa, Rim, Kattan, Joseph, Khalifeh, Ibrahim, Mukherji, Deborah, Temraz, Sally, Alqasem, Kholoud, Amarin, Rula, Al Awabdeh, Tala, Deeba, Samer, Jamali, Faek, Mohamad, Issa, Elkhaldi, Mousa, Daoud, Faiez, Al Masri, Mahmoud, Dabous, Ali, Hushki, Ahmad, Jaber, Omar, Charafeddine, Maya, Geara, Fady
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7542723/
https://ncbi.nlm.nih.gov/pubmed/33028346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-020-01673-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky